InvestorsHub Logo
Followers 69
Posts 6547
Boards Moderated 0
Alias Born 02/10/2010

Re: ddls post# 330208

Tuesday, 06/18/2024 5:33:51 PM

Tuesday, June 18, 2024 5:33:51 PM

Post# of 331789
So Sorry if the Facts Intimidate You, They are Still the Facts None the Less

Dr Reddy's invested in marketing a new non-drug wearable for pain relief. (Bullish for Electroceuticals).

The Nerivio is priced at $180 and provides 36 days of therapy, per the article. (ActiPatch provides 30 days of therapy for $34.95).

Nerivio's Side Effects, Nausea, Photophobia, and Phonophobia are listed in the 510k Summary #K201824 page 8. (ActiPatch = Zero Side Effects)

The NerivioInfinity Rechargeable did not require any new Clinicals per 510k #K232152, final page, which was submitted 7/19/2023 and Cleared on 11/08/2023.
(ActiPatch will be in a similar situation when they file a 510k for the Rechargeable version, therapeutic elements, electrical waveform, location on the body, treatment instructions, treatment duration, all are the same)

Why don't you go whip up some new 'Fake News' about BIEL to make yourself feel better.